Association of busulfan area under the curve with veno-occlusive disease following BMT.S P Dix, Rein Saral, Leonard T. Heffner et al.|PubMed|1996Cited by 323
Venetoclax for patients with chronic lymphocytic leukemia who progressed during or after idelalisib therapySteven Coutré, Matthew S. Davids, Michael Y. Choi et al.|Blood|2018Cited by 132
Utility of positron emission tomography-computed tomography in patients with chronic lymphocytic leukemia following B-cell receptor pathway inhibitor therapyAnthony R. Mato, John C. Byrd, William G. Wierda et al.|Haematologica|2019Cited by 40
Analysis of PET-CT to Identify Richter's Transformation in 167 Patients with Disease Progression Following Kinase Inhibitor TherapyAnthony R. Mato, Jeffrey A. Jones, William G. Wierda et al.|Blood|2017Cited by 18
Venetoclax for chronic lymphocytic leukaemia patients who progress after more than one B‐cell receptor pathway inhibitorWilliam G. Wierda, Michael Y. Choi, John C. Byrd et al.|British Journal of Haematology|2018Cited by 15